Skip to content

GALMED PHARMACEUTICALS LTD.

GLMD

CIK 0001595353

← back to feed
Revenue (TTM)
$0
FY Dec 2025
Net Income (TTM)
−$7.41M
−37.1% YoY FY Dec 2025
EPS Diluted (TTM)
$4.92
−70.4% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
—
FY Dec 2025
Net Margin
—
FY Dec 2025
Free Cash Flow (TTM)
−$6.32M
FY Dec 2025
Cash
$3.99M
FY Dec 2025
Total Debt
$0
FY Dec 2025
Shares Outstanding
6.58M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings